Comparing Empagliflozin / Linagliptin vs Ertugliflozin / Sitagliptin
| Empagliflozin / linagliptin | Ertugliflozin / sitagliptin |
|
|---|
| Empagliflozin / linagliptin | Ertugliflozin / sitagliptin |
|
|---|---|---|
|
Prescription only
Prescribed for Type 2 Diabetes. Empagliflozin / linagliptin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Type 2 Diabetes. Ertugliflozin / sitagliptin may also be used for purposes not listed in this medication guide. |
Related suggestions Type 2 Diabetes
|
| More about Empagliflozin / linagliptin | More about Ertugliflozin / sitagliptin | |
| Ratings & Reviews | ||
|
Empagliflozin / linagliptin has an average rating of 6.7 out of 10 from a total of 23 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 26% reported a negative effect. |
Ertugliflozin / sitagliptin has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Glyxambi | Steglujan | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
12.4 hours |
16.6 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 483 drugs are known to interact with Empagliflozin / linagliptin:
|
A total of 400 drugs are known to interact with Ertugliflozin / sitagliptin:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
|
|
| Disease Interactions | ||
| First Approval Date | ||
|
January 30, 2015 |
December 19, 2017 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
|
N/A |
N/A |
|
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Mounjaro
Mounjaro (tirzepatide) is FDA-approved to manage type 2 diabetes in adults. It lowers blood sugar ...
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Basaglar
Basaglar (insulin glargine) is a long-acting insulin that is used to improve blood sugar control in ...
Levemir
Levemir (insulin detemir) is a long acting insulin used to treat diabetes in adults and children ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.